IBIO vs PCG · rev $100.0K vs P/E 13, rev $12.78B
iBio, Inc. Common Stock (IBIO) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported PCG revenue for 2026-06-30 was $12.78B. Net income was $1.65B. Revenue was up 85.8% from 2026-03-31 to 2026-06-30. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
IBIO currently screens at market cap $13.4M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the IBIO and PCG stock pages for the full models.
Not investment advice.